Key facts
- It has raised $27.9M; the latest was Later Stage VC ($26.0M) in Mar 2026.
- Notable investors include US National Science Foundation, National Institutes of Health, E14 Fund, Massachusetts Institute of Technology, BioTools Innovator — 10 tracked in total.
- Status: Privately Held (backing).
Investors
10- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Ramona
- ·The full record, as it builds
Funding rounds
No funding rounds for Ramona are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ramona
Manufacturer of a microscopy toolset intended to capture cellular-level detail over hundreds of square centimeters. The company's microscope uses custom-designed control electronics to deliver and process massive amounts of image data from a large array of micro-cameras, enabling companies to capture, analyze, and securely store tens of gigapixels of object-specific data with high throughput and improved analysis.
- Sector
- Information Technology
- HQ
- Durham, NC, United States
- Founded
- 2017
- Employees
- 69
- Website
- ramonaoptics.com/
- Ownership
- Privately Held (backing)
Ramona doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ramona shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ramona in its N-PORT filings yet. We sweep new filings monthly.